Treatment outcomes in 1p19q co-deleted/partially deleted gliomas.
| dc.contributor.author | McNamara, Mairéad G | |
| dc.contributor.author | Jiang, H | |
| dc.contributor.author | Lim-Fat, M | |
| dc.contributor.author | Sahebjam, S | |
| dc.contributor.author | Kiehl, T | |
| dc.contributor.author | Karamchandani, J | |
| dc.contributor.author | Coire, C | |
| dc.contributor.author | Chung, C | |
| dc.contributor.author | Millar, B | |
| dc.contributor.author | Laperriere, N | |
| dc.contributor.author | Mason, W | |
| dc.date.accessioned | 2017-07-07T16:19:01Z | |
| dc.date.available | 2017-07-07T16:19:01Z | |
| dc.date.issued | 2017-05 | |
| dc.identifier.citation | Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas. 2017, 44 (3):288-294 Can J Neurol Sci | en |
| dc.identifier.issn | 0317-1671 | |
| dc.identifier.pmid | 28488951 | |
| dc.identifier.doi | 10.1017/cjn.2016.420 | |
| dc.identifier.uri | http://hdl.handle.net/10541/620434 | |
| dc.description.abstract | Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma. | |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | en |
| dc.title | Treatment outcomes in 1p19q co-deleted/partially deleted gliomas. | en |
| dc.type | Article | en |
| dc.contributor.department | Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada | en |
| dc.identifier.journal | The Canadian Journal of Neurological Sciences | en |
| refterms.dateFOA | 2020-04-21T14:22:05Z | |
| html.description.abstract | Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma. |
